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Materials and Methods 
Production of 63CuSO4 
 50 mg aliquots of 63CuO (Cambridge Isotope Laboratories) were dissolved in 1.5 mL of 3 
M trace metal grade H2SO4 while heating at 60-80°C and shaking at 300 rpm. The reaction was 
judged to be complete when no black CuO particles were visible in the blue CuSO4 solution (after 5 
several days).   
 
Growth of M. capsulatus (Bath) and preparation of Vivo-pMMO EPR sample 
 Isotopically enriched 63Cu, 15N-M. capsulatus (Bath) was grown in a 12 L bioreactor as 
described previously with minor modifications (13, 23). Briefly, cells were grown in a solution of 10 
3.9 mM phosphate buffer, pH 6.8, 40 µM NaFe(III)EDTA, trace element solution, 50 µM 63CuSO4 
and 1X 15N-nitrate mineral salts (NMS) (Cambridge Isotopes Laboratories, potassium 15N-nitrate) 
with a constant flow of 1:4 methane-to-air gas mix. NaOH and H2SO4 were used to maintain the 
growth medium pH between 6.7 and 7.4. Cells were harvested by centrifugation (6,000 x g for 20 
min at 4°C) at OD600 of 11.3. Of this yield, 0.75 g of cell pellet was set aside on ice, while the rest 15 
was frozen in liquid nitrogen and stored at -80°C. To prepare whole cell EPR samples, the 0.75 g 
of cell pellet was resuspended in 50 mL of 12.2 mM dibasic sodium phosphate, 7.8 mM monobasic 
sodium phosphate, 5 mM magnesium chloride, pH 7.0 and centrifuged at 4°C, 10,000 x g, for 10 
min, as done previously (49). The supernatant was poured off, the wash and centrifugation 
procedure was repeated, and the supernatant was again poured off. The cells were resuspended in 20 
200 µL of phosphate buffer, and this suspension was then aliquoted into a Wilmad quartz X-band 
EPR tube (Sigma Aldrich) and custom quartz Q-band EPR tube (~180 µL and ~80 µL, 
respectively, as with all EPR samples in this study). EPR samples were frozen in liquid nitrogen, 
where they were stored until analysis. Natural abundance M. capsulatus (Bath) was grown and 
harvested under similar conditions except natural abundance CuSO4 and NMS were used for the 25 
growth medium instead of 63CuSO4 and 15N-NMS. 
 
pMMO purification and X-band Continuous Wave (CW) and Q-band EPR/ENDOR sample 
preparation 
 M. capsulatus (Bath) cells were resuspended in 25 mM PIPES, 250 mM NaCl, pH 7.2-7.3 30 
and lysed by sonication (either using 90% power setting, 1 s on, 1 s off sonication for 10 min, or 
a 90% power setting, 1 s on, 2 s off sonication for 8 min) and membranes containing pMMO were 
isolated, solubilized, and purified by size exclusion chromatography (using a 120 mL Superdex 
200 equilibrated in 25 mM PIPES, 250 mM NaCl, 0.02 % DDM, pH 7.2-7.3, 1 mL/min flow rate) 
as described previously (13, 50), although for this study the solubilized membranes were 35 
concentrated to 2 mL (rather than 1 mL) before running size exclusion chromatography and the 
PIPES buffer used throughout (i.e. with and without DDM) was kept at pH 7.2-7.3 (rather than pH 
7.0). After size exclusion chromatography, the sample was concentrated via centrifugation at 5,000 
x g, at 4°C using a 100 kDa cutoff Amicon spin concentrator; samples were subsequently either 
frozen in liquid nitrogen and stored at -80°C until use, or, to make Purified-pMMO EPR samples, 40 
aliquoted into X- or Q-band EPR tubes and frozen in liquid nitrogen. To generate 
Reduced/Purified-pMMO, Purified-pMMO was degassed and made anaerobic on a Schlenk line, 
and then brought into a Coy anaerobic glovebox. 10-12 protein equivalents of sodium ascorbate in 
anaerobic 25 mM PIPES, pH 7.5 or 25 mM PIPES, 250 mM NaCl, 0.02 % DDM, pH 7.5 were 
added to the protein solution. Reduced/Purified-pMMO samples were allowed to equilibrate for at 45 
least 1 hr at room temperature in the glovebox before being aliquoted into X- or Q-band EPR tubes 
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which were frozen in liquid nitrogen in the glovebox. While the CuC(II) EPR signal was always 
significantly more diminished by ascorbate reduction than the CuB(II) signal, occasionally some 
CuC(II) was apparent even after this procedure. When this occurred, the sample was thawed 
anaerobically, and ascorbate was added until the CuC(II) signal was no longer evident. For 
Purified-pMMO in D2O samples, the protein was buffer exchanged into 25 mM PIPES, 250 mM 5 
NaCl, 0.02% DDM buffer in D2O (99.9%-D, Sigma-Aldrich), pD 7.3. To prepare 
Reduced/Purified-pMMO in D2O, Purified-pMMO in D2O was anaerobically reduced as above 
except the ascorbate was prepared in the deuterated buffer mentioned above (made anaerobic). 
Unless otherwise noted, the concentrations of all EPR/ENDOR samples of Purified- or 
Reduced/Purified-pMMO were comparable, only varying between 300 and 500 µM. 10 
For Purified-pMMO incubated with nitrite, NaNO2 was dissolved in 25 mM PIPES, 250 
mM NaCl, 0.02% DDM, pH 7.2 to generate a 4 M NaNO2 stock solution. An equal volume of this 
stock and natural abundance Purified-pMMO were mixed, and the sample was incubated at room 
temperature for 2 hr and 15 min. The sample was then transferred to either an X-band or Q-band 
EPR tube and flash frozen in liquid nitrogen.  15 
For Purified- and Reduced/Purified-pMMO samples incubated with H217O, the enzyme 
was desalted into 2X wash buffer (50 mM PIPES, 500 mM NaCl, 0.04% DDM, pH 7.2) using a 
PD-10 desalting column at 4°C. The protein was concentrated to 90 µL, ~630 µM protein using a 
100 kDa cutoff Amicon filter. The protein was then diluted with 90 µL of 90% 17O-enriched H2O 
(Sigma Aldrich). To generate the Purified-pMMO in H217O, 80 µL of this sample was put in a Q-20 
band EPR tube inside of a cryotube, parafilmed to make airtight, and then left in the dark at room 
temperature overnight. To generate the Reduced/Purified-pMMO, with the remaining 100 µL of 
pMMO, the protein was made anaerobic using a Schlenk line and brought into the glovebox, where 
it was treated with 12 protein equivalents of ascorbate (in anaerobic 25 mM PIPES, 250 mM NaCl, 
0.02% DDM, pH 7.2). The protein was incubated overnight in the dark at room temperature in the 25 
glovebox. In the morning this sample was transferred to a Q-band EPR tube. Both Q-band samples 
were flash frozen in liquid nitrogen in the morning (the anaerobic sample was flash frozen in the 
glovebox). 
   
Design, expression, and purification of spmoB constructs and NeMCO 30 
 spmoB was recombinantly expressed in E. coli into inclusion bodies and refolded in 20 
mM Tris, 250 mM NaCl, pH 8.0 as described previously (27), except Tris base was used instead 
of Tris-Cl. 
 To optimize spmoB solubility and create a solubly expressing spmoB construct, we 
redesigned the artificial flexible linker that connects PmoB subdomain 1 (PmoB D1) and 35 
subdomain 2 (PmoB D2) in spmoB, and tested various combinations of N- and C-terminal soluble 
tag attachments to spmoB. To reduce flexibility and aggregation propensity, the original linker in 
spmoB was replaced with the following sequence: PmoB(residues 173-182)-GEPS-Protein GB1-
GE-PmoA(residues 170-203)-S, which is followed by the D2 domain starting with PmoB residue 
267 (Fig. S9), in which Protein GB1 is the B1 domain of Protein G. Solubility improvements were 40 
screened by the split-GFP assay and confirmed by SDS-PAGE (51). Out of the screened variants, 
constructs Con7 with a Set12 tag (Set12 is is the T7B9 peptide (52)) at both C- and N-termini, and 
SUMO7 (Con7 with an additional N-terminal SUMO tag) were identified to be solubly expressed 
at ≥10 mg/L in E. coli (Fig. S9). In order to test whether the foldedness of the copper-binding 
PmoB D1 affects the activity, error-prone PCR was performed on the PmoB D1 subdomain alone, 45 
and the resulting variants were selected by a twin-arginine translocation (TAT) pathway-based 
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ampicillin survival assay, which has been shown to isolate variants with improved folding (53, 
54). From this assay, a single amino acid mutation variant (PmoB D1_E75D) was identified to 
grant host expression E. coli cells with improved ampicillin survival rate than PmoB D1_WT, and 
assembled back to the SUMO7 construct to create SUMO7_E75D. To validate that methanol 
produced in the methane oxidation activity assays was a result of enzymatic turnover at the 5 
previously reported pMMO active site (CuB), we produced two negative control constructs which 
should have exhibited no methane oxidation activity. For SUMO7_3A, the three CuB residues 
(H33, H137, and H139) were mutated to alanine to abrogate copper binding at this site. The second 
negative control was a multicopper oxidase (NeMCO, derived from Nitrosomonas europaea)(55) 
that does not oxidize methane.  10 
 SUMO7, SUMO7_E75D, SUMO7_3A, and NeMCO were expressed in chemically-
competent E. coli BL-21(DE3)Gold cells by either auto induction or IPTG induction. For auto 
induction, 5 mL of overnight culture in LB with 100 µg/mL of ampicillin (Amp100) was 
inoculated into1 L of ZYM-5052 media with Amp100 at 37℃ until OD600 hit 0.5, and then at 20℃ 
for 24 hours to express protein (56). For IPTG induction, 1 L of LB/Amp100 was inoculated by 5 15 
mL of overnight culture at 37℃, and induced by 1 mM IPTG at OD600 between 0.6 and 1.0. 
Expression was then conducted at 27℃ for 4 hours. Post-expression culture was transferred to a 
capped bottle, supplemented with water to replace the headspace gas, and treated with 1x ZYM-
5052 sugar solution together with 1 mM of CuSO4 for 2 hours to allow in-vivo copper loading (56). 
Cells were then harvested, lysed by a cell disruptor, and centrifuged at 15,000 x g for 40 min. 20 
Soluble protein was then purified by Strep-Tactin beads (IBA) and stored in either 1x PBS (137 
mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4) or 1x TBS (50 mM Tris, 
150 mM NaCl, pH 7.6). Protein was concentrated by 30kDa MWCO spin-filters (Amicon) to ≤ 1 
mL volume before further analysis.  
 For the refolded SUMO7 sample, soluble protein was expressed in C41(DE3) chemically 25 
competent E. coli cells in ZYM-5052 autoinduction media with 50-100 µg/mL ampicillin at 37°C 
(56). After the OD600 reached ~0.5, the temperature was lowered to 18°C for overnight expression. 
Cells were harvested by centrifugation, frozen in liquid nitrogen and stored at -80°C until use. 
Cells were then thawed and resuspended in 50 mM Tris, 150 mM NaCl, pH 8.0 and lysed by 
sonication; cell debris was pelleted by centrifugation, and the protein was purified via Strep-Tactin 30 
column (IBA-GMBH). After purification, the protein was unfolded in 8 M urea at a protein 
concentration of 0.7 mg/mL (protein concentration determined using the Pierce™ 660 nm assay 
(VWR International) and a molecular weight of 69.292 kDa) and was subsequently refolded in the 
presence of CuSO4 following a previously described protocol (24). After refolding, the protein was 
ultracentrifuged for 40 min at 125,000 x g, 4°C, and concentrated using a 10 kDa cutoff Amicon 35 
spin concentrator. Aliquots of 50 µM SUMO7 were then immediately tested for methane oxidation 
activity, and the rest of the protein was frozen in liquid nitrogen and stored at -80°C until later use. 
To prepare the refolded SUMO7 X-band EPR sample, protein was thawed, concentrated using an 
Amicon spin concentrator to 250 µM, transferred to a Wilmad quartz X-band EPR tube and frozen 
in liquid nitrogen. 40 
 
Optical spectroscopy 
 All optical spectroscopy measurements were performed on an Agilent 8453 
spectrophotometer with an Agilent 89090A Peltier temperature controller. 
 45 
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Methane oxidation activity assays 
 All Purified- and Reduced/Purified-pMMO preparations used to produce paramagnetic 
resonance spectroscopy samples were verified as active (capable of catalyzing methane oxidation) 
using a very slightly adjusted bicelle-reconstitution 13C methane oxidation activity assay (13). 
Duroquinol was generated from duroquinone (VWR International) as described previously (25). 5 
For all methane oxidation activity assays, 100 µL of 2.6-8.0 mg/mL purified pMMO in 3-6% 
DMPC:CHAPSO 2.8:1 bicelle solution (Molecular Dimensions or Anatrace), or 100 µL of 
spmoB/spmoB construct (concentrations and length of reaction provided in figures), were mixed 
with a small scoop of duroquinol placed into sealed septa top vials (Agilent). A 2:1 ratio of 13C-
methane (Sigma-Aldrich) and air, totaling 3 mL, was injected into the top. Reactions were 10 
incubated in a water bath shaking at 200 rpm (at least 5 min at 30°C for pMMO, otherwise 
temperature and time of reaction are provided in figures) after which point the reactions were either 
immediately stopped using 500 µL of chloroform spiked with 1 mM dichloromethane or were 
frozen and later thawed; upon thawing 500 µL of chloroform spiked with 1 mM dichloromethane 
was added to the vial. The amount of 12/13C-methanol after reaction was determined using a 15 
PoraBOND Q column (Agilent) on an Agilent 7890B/5977A MSD GC/MS instrument monitoring 
the 33 m/z ion (13C-methanol) and 31 m/z ion (12C-methanol) relative to the 49 m/z ion 
(dichloromethane internal standard) as described previously (13). The GC oven temperature 
holding times were varied to adjust for changing retention times over the life of the GC column. 
Absolute 13C-methanol concentrations were determined by comparison of 13C-methanol peak 20 
intensities to those of known concentration 13C-methanol (Sigma-Aldrich) standards in buffer. A 
signal-to-noise cutoff of 1.0 for the 13C-methanol integrated peak area was used to distinguish real 
signal from noise; samples with signal-to-noise less than 1.0 were treated as 0 µM 13C-methanol. 
 
X-band CW-EPR and Q-band ENDOR measurements 25 
 All CW X-band EPR measurements (except those of SUMO7) were performed using a 
Bruker ESP-300 spectrometer with a liquid helium flow Oxford Instruments ESR-900 cryostat. 
SUMO7 EPR was measured on a modified Varian E-4 with a liquid nitrogen finger-dewar at 77 
K. All wide scans spanning ≥1000 G were background subtracted. Collection conditions (Fig. 1, 
wide and inset scans): 9.36-9.37 GHz microwave frequency, 90 s per scan, 320 ms time constant, 30 
12.5 G modulation amplitude, temperature at 20 K, at least 5 scans. SI spectra collection conditions 
are provided below the figures. All EPR simulations were performed using EasySpin (57).  
 Pulsed ENDOR measurements were collected at ~2 K in a liquid helium immersion dewar 
on a spectrometer described elsewhere, with SpinCore PulseBlaster ESR_PRO 400MHz digital 
word generator, and Agilent Technologies Acquiris DP235 500 MS/sec digitizer using SpecMan 35 
software (58, 59). For all 1H and strongly-coupled 15N ENDOR measurements, a Davies [π–TRF–
π/2–τ–π–τ–echo] pulse sequence was employed, in which TRF denotes the interval during which 
the RF was applied. For weakly-coupled remote 15N ENDOR measurements, a Doan/ReMims 
[π/2–τ1–π/2–TRF–π/2–τ2–π–(τ1 + τ2)–echo] or a Mims [π/2–τ–π/2–TRF–π/2–τ–echo] pulse 
sequence was employed (60). Hyperfine coupling (A) of I = 1/2 nuclear spin (15N and 1H) and S = 40 
1/2 electron spin (Cu(II)) produce an ENDOR spectrum given by the equation 𝑣± = |𝑣% ± &' |, 
where v+ and v- are the high and low frequency peaks of the doublet, respectively, while vn is the 
Larmor frequency for the nucleus (n). For Fig. 2, collection conditions were as follows: (strongly-
coupled 15N) 34.592 GHz microwave frequency, 100 ms repetition time, π = 80 ns, τ = 600 ns, TRF 
= 15 µs, and RF tail = 5 µs; (weakly-coupled 15N) 34.608 GHz microwave frequency, 20 ms 45 
repetition time, π = 60 ns, τ1 = 200 ns, τ2 = 400 ns, TRF = 60 µs, and RF tail = 10 µs, 15N-Larmor 
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corrected. The sign of the 15N hyperfine coupling was determined through the Pulsed ENDOR 
Saturation Recovery (PESTRE) experiment (Fig. S14), which provides the absolute sign of A/gn 
(61).  
 
X-band pulsed DEER sample preparation and measurements 5 
 75 µL of 360 µM natural abundance Purified-pMMO in 2X wash buffer (50 mM PIPES, 
500 mM NaCl, 0.04% DDM, pH 7.2) was aliquoted into a Wilmad quartz X-band EPR tube. The 
altered buffer conditions do not affect the Cu(II) ligation (Fig. S15). X-band pulsed EPR spectra 
were recorded on a Bruker E680 spectrometer (Bruker, Rheinstetten, Germany) using a Bruker 
MD5-W1 EPR probehead equipped with a self-modified cryogen-free cryostat (Advanced 10 
Research Systems Inc, Macungie, PA, USA). The microwave pulses were amplified using a 1kW-
TWT (Applied Systems Engineering Inc., Fort Worth, TX, USA). All EPR experiments were 
carried out at 17K. The field-swept spectrum was obtained by integrating the Hahn echo signal as 
a function of the magnetic field after a two-pulse sequence.  
 For the 4-pulse PELDOR experiments recorded at 17 K, pulse lengths were 20 nsec for π/2 15 
and 20 nsec for π. The pump pulse length was 16 nsec and ∆ν (νobs – νpump) was 80 MHz, with the 
detection field set at a g value of 2.07. The pulse separation τ1 was 200 nsec while τ2 varied between 
2500-3500 ns, and the echo signals were integrated using a video amplifier bandwidth of 20 MHz. 
The pump pulse was stepped out by 16 nsec for a total number of points in T that depended upon 
the τ2 used. Nuclear modulation artifacts were suppressed using a systematic variation of the 20 
interpulse delay time τ1 and an appropriate phase cycling routine. 
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Supplementary Text 
 
Discrepancy between the paramagnetic resonance analysis and previous data supporting a dicopper 
site  
Previous EXAFS scattering was fit with a short Cu-Cu distance (~2.5-2.6 Å) indicative of a 5 
dicopper center. However, all three possible oxidation states of a dicopper center, Cu(II)-Cu(II), 
Cu(II)-Cu(I), or Cu(I)-Cu(I), are not consistent with the current analysis. Two Cu(II) ions at ~2.5-
2.6 Å separation, with no magnetic interaction between them, would produce a large dipolar 
splitting in the EPR spectrum that is not observed. A (anti)ferromagnetically coupled Cu(II)-Cu(II) 
center would not contribute to the paramagnetic resonance spectroscopy, but we do not observe 10 
the characteristic charge transfer optical absorbance features associated with the superexchange 
coupling pathway requisite to forming such centers (62, 63). To the best of our knowledge, there 
is no dicopper Cu(I)-Cu(I) metal site in biology that does not oxidize in air, so if a Cu(I)-Cu(I) site 
were present, it would oxidize to either Cu(II)-Cu(I) or Cu(II)-Cu(II) during the aerobic 
purification procedure. In addition, in previous studies from our laboratory (13, 15), Cu(II) EPR 15 
spin quantitation of purified pMMO indicated that nearly all Cu in the protein is EPR active Cu(II), 
inconsistent with a dicopper Cu(I)-Cu(I) site. Finally, we consider a Cu(II)-Cu(I) center. As noted 
previously, we do not observe any of the characteristic features associated with such valence-
delocalized center (24). As described in the main text, the 4 N ligands in the CuB site all are bound 
to the single Cu(II) giving rise to the CuB EPR signal; the terminal NH2 and the side chains of 20 
His33, His137, and His139 are coordinated in a square plane of equatorial coordination. Thus, 
there are no ligands available to coordinate a second copper ion, excluding the possible presence 
of a valence-localized Cu(II)-Cu(I) site. Viewed from a different perspective, the Cu(II) EPR 
signal from spmoB differs from that of CuB in pMMO, yet the EXAFS for both proteins was fit 
with the same Cu-Cu scattering interaction (within ~0.1 Å) (27). It is implausible that the two 25 
samples with distinct copper centers coincidentally both contain dicopper centers with the same 
Cu-Cu distance. The optical absorbance feature proposed to be assignable to a dicopper site in 
pMMO is discussed in the caption to Fig. S5, and spmoB methane oxidation activity proposed to 
occur at a dicopper CuB site is discussed in the caption to Fig. S11.  
 30 
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Table S1. Summary of the paramagnetic spectroscopic parameters of the CuB and CuC sites.* 
 
g1, 
g2, 
g3 
Cu 
A1, 
A2, 
A3 
(MHz) 
Directly 
Coord. 
15N A1, A2§  
(MHz)† 
Remote 
15N |A1| 
(MHz) 
 
1H A1, A2 
(MHz)‡ 
CuB 
2.242, 
2.068, 
2.035 
570, 
30, 
14 
-48, -54 
-53, -54 
-53, -54 
-53, -66 
1.7 
2.3 
2.3 
N/A 
His33-NH2 
Hε-1 
Hε-2 
Hβ 
Hδ 
~10, ~10 
- , 4.5 
- , 2.5 
- , ~1 
- , ~1 
      
CuC 
2.30, 
2.07, 
2.05 
440, 
40, 
20 
-48, -54 
-53, -66 ~2 HxO ~8, ~10 
 
* For simulations featuring the full Vivo-, Purified-, and Reduced/Purified-pMMO EPR spectra in 
Fig. 1 using the above parameters, anisotropic g-strain (for both CuB and CuC, EasySpin g-strain 
parameters 0, 0, 0.03 for g3, g2, g1, respectively) was employed, with additional isotropic 14 G and 5 
25 G fwhm Gaussian line width broadening for CuB and CuC, respectively. For simulations 
depicted in insets, the CuB g1 value was changed very slightly to 2.252, and isotropic 13 G fwhm 
Gaussian line width broadening was employed, with no anisotropic broadening. Simulation of 
Purified-pMMO represents the sum of 1 CuB equivalent and 0.32 CuC equivalents. For comparison 
to 14N ENDOR measurements, see Table S3. 10 
§ Strongly-coupled 15N A2 ENDOR measurements are shown in Fig. S16. The four features seen 
in these spectra are plausibly, but not uniquely assigned as listed. 
† PESTRE experiments determined that all directly-coordinated 15N possess positive spin density 
ρ > 0 (Fig. S14); the 15N hyperfine couplings are therefore negative because the 15N nuclear gn < 
0.  15 
‡ The 1H ENDOR assignment to individual C-H/N-H bonds of the histidine imidazole ring and 
amine are made by analogy to Cu(II)(histidine)2 complex (34). 
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Table S2. Vivo-pMMO 15N A1 Gaussian fitting parameters used in Fig. 2.* 
 Resonance Gaussian Function Parameters R2 
Remote 15N 
 
 
Red 
 
k = 30.32 
 
a1 = 0.08824 
b1 = 0.8631 
 
0.997 
Blue§ 
 
a2 = 0.1194 
b2 = 1.149 
 
Directly-
coord. 15N 
 
 
Red 
 
k = 6.57  
 
a1 = 1.341 
b1 = 27.5 
 0.9938 
Blue† a2 = 1.329 b2 = 32.28   
 
a3 = 1.75 
b3 = 31.13 
 
 
a4 = 0.9132 
b4 = 30.77 
 
* The colors red or blue define the color of the Gaussian curves shown in Fig. 2, which were used 
to fit the 15N v+ resonance. R2 values correspond to the fit of the full normalized Gaussian function 
to the experimental spectrum over a range of 𝑣 − 𝑣 )*+ = 0.627-1.604 MHz for remote 15N, and 
over a range of 25.651-28.043 MHz for directly-coordinated 15N resonance. The MatLab Curve 5 
Fitting tool was used to fit the Gaussian function parameters, using the following equations: 
normalized Gaussian function,  
remote 15N:     	𝑓(x) = 𝑘 2 34*√'6 𝑒8(9:;*)<<(=*)< + 2 34<√'6 𝑒8(9:;<)<<(=<)< @,  
 
directly-coordinated 15N:  10 𝑓(x) = 𝑘 2 34*√'6 𝑒8(9:;*)<<(=*)< + 34<√'6 𝑒8(9:;<)<<(=<)< + 34A√'6 𝑒8(9:;A)<<(=A)< + 34B√'6 𝑒8(9:;B)<<(=B)< @,  
 
 where k is a factor that scales calculated and experimental spectra, an is related to the width of the 
peak (in MHz), and bn defines the center of the Gaussian peak (in MHz).  
§ In Fig. 2 the blue peak intensity is twice that produced by simply using the parameters to account 15 
for the fact that the function used for total fitting also doubles the intensity of this peak relative to 
the red peak 
† Blue, directly-coordinated 15N resonance function is defined by the sum of three equal area 
Gaussian functions 
  20 
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Table S3. Conversion of 15N hyperfine coupling to equivalent 14N hyperfine coupling for 
comparison with past characterization of Purified pMMO. 
 
 15N |A1| (MHz) 14N |A1| (MHz) Source 
15N-labelled A1-15N1 
A1-15N2 
48 
53 
[34]† 
[38]† 
This study 
Natural abundance N/A 35.5 (24) 
 
† Values in brackets correspond to hyperfine coupling predicted based on conversion between the 5 
two nuclear gyromagnetic ratios: 𝐴 )*+ = 1.403(𝐴 )*B ) , (64). The two distinguishable 15N 
hyperfine couplings observed with 15N-labelled Purified-pMMO are not resolved from one another 
in the natural abundance Purified-pMMO 14N ENDOR spectrum from (24), presumably due to the 
substantial quadrupolar broadening of the 14N ENDOR response.  
  10 
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Fig. S1. (A) One protomer of the M. capsulatus (Bath) pMMO modeled with an unoccupied PmoC 
metal site and a Cu-bound bis-His site. Inset: A closer view of the bis-His site. (B) Full pMMO 5 
trimer with CuB to bis-His Cu distances (inset). 
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Fig. S2. Support for the assignment of 4 directly coordinated N equatorial ligands on CuB from the 
EPR shown in Fig. 1. We first distinguished the region corresponding to CuB(II) resonance from 
resonance attributable to the contaminant paramagnet(s) clearly present at the high and low field 
edge of the Vivo-pMMO single Cu(II) hyperfine line in this region. Toward this end, we measured 5 
the total width of the low field CuB(II) hyperfine line in Reduced/Purified-pMMO (left, bottom), 
since this spectrum does not contain these contaminants. Specifically, we measured the width of 
the total resonance to the left and to the right of the hyperfine transition maximum height peak. 
We then used these bounds to define the CuB(II) resonance in Vivo-pMMO (left, top and right). 
There are 5 evenly spaced local minima in the second derivative (green) of the experimental 10 
spectrum, as well as the 5 corresponding evenly spaced local maxima, as shown by the circles in 
the figure below, indicative of 5 hyperfine lines. Additionally, these peak and valley features 
clearly correspond to the expected splittings on the absorption-like experimental spectrum. 5 
hyperfine lines can only be accounted for by 4 approximately equivalent I = 1/2 nuclei, such as 
that expected from 4 15N equatorial ligands.  15 
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Fig. S3. 1H and 15N Davies ENDOR for Vivo-, Purified-, and Reduced/Purified-pMMO. Times 
incubated in D2O buffer are listed. (A) ENDOR measurements simultaneously probing 15N and 
1H, with heights normalized to echo intensity. Filled circle defines half the 15N hyperfine coupling 
magnitude (|A/2|) and associated goalpost width indicates twice the 15N Larmor frequency (𝑣 )*+ ); 5 
triangle defines the 1H Larmor frequency (𝑣 I* ) and associated goalpost width defines hyperfine 
coupling magnitude (|A|). The weakly-coupled 1H resonance (A < ~5 MHz) in Vivo-pMMO that 
is less intense in Reduced/Purified-pMMO is attributed to solvent HxO near the CuB site in vivo 
that is not present in purified enzyme. Collection conditions: 34.5-34.6 GHz microwave frequency, 
100 ms repetition time, π = 200 ns, τ = 600 ns, TRF = 60 µs, and RF tail = 10 µs. (B) 1H Larmor-10 
centered 1H ENDOR measured at (left) g1 and (right) g2, where triangle defines the 1H Larmor 
frequency (𝑣 I* ) and goalpost width defines the hyperfine coupling magnitude (|A|). Vivo-, 
Purified-, and Reduced/Purified-pMMO ENDOR intensities were normalized to ENDOR 
intensities in (A). Insets highlight the increased intensity and altered lineshape of the Purified-
pMMO large coupling 1H resonance relative to Reduced/Purified-pMMO, evidence for a 15 
coordinated HxO (with hyperfine coupling, |A1| ~ 8 MHz, |A2| ~ 10 MHz) (65) on CuC. Collection 
conditions: 34.5-34.8 GHz microwave frequency, 100 ms repetition time, π = 200 ns, τ = 600 ns, 
TRF = 60 µs, and RF tail = 10 µs. 
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 5 
Fig. S4. One protomer of M. capsulatus (Bath) pMMO from the crystal structure in Fig. 1, with 
all protomers colored gray, shown from several angles, with His residues highlighted in pink. The 
CuB site is the only site where three His side chains come together.  
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Fig. S5. UV-Vis spectra monitoring formation of the 345 nm optical feature. A sample of 25 mM 
PIPES, 250 mM NaCl, 0.02% DDM, pH 7.2 (M. capsulatus (Bath) Purified-pMMO wash buffer) 5 
with 120 µM CuSO4 (to represent the Cu equivalents present in the pMMO sample used previously 
(37)) and 4 µM methanol (to represent background-level contamination present to varying degrees 
in most pMMO preparations) was made anaerobic in a sealed cuvette and incubated with 5 Cu(II) 
equivalents of ascorbate for 30 min. 2.5 Cu(II) equivalents of H2O2 were then added using a gas-
tight syringe, and optical spectra were measured every 15 min for 12 hr at room temperature. 10 
Formation of the 345 nm feature is observed on the timescale defined previously (37) and can be 
attributed to ketal derivatives of dehydroascorbic acid generated by the reaction of ascorbate and 
H2O2 (66). The drifting baseline in early timepoints is an instrument artifact. The variable intensity 
of the 345 nm feature previously observed upon mutation of the CuB ligands is likely due to the 
strong dependence of dehydroascorbic acid ketal derivatives on trace metals for stability, since 15 
mutation of the copper binding ligands leads to lowered levels of copper in the sample. Consistent 
with this conclusion, close inspection of the spmoB_H137,139A (CuB ligating His residues 
mutated) optical spectrum reveals the presence of a small amount of 345 nm absorbance despite 
mutation of two of the three CuB His ligands (37). Conversely, the spmoB_H48N_137,139A (bis-
His and CuB residues mutated) optical spectrum shows no evidence of 345 nm absorbance. The 20 
only difference between spmoB_H137,139A and spmoB_H48N_137,139A is mutation of the 
nonconserved bis-His residue His48. This mutation decreases the total amount of Cu bound by the 
protein by approximately 0.5 Cu equivalents (24). The reason this was not noted previously was 
likely the low intensity of the 345 nm feature in the spmoB_H137,139A optical spectrum. 
  25 
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Fig. S6. EPR and ENDOR characterization of (all samples were natural abundance N and Cu) 
Purified- and Reduced/Purified-pMMO with H217O. (A) X-band EPR measurements assessing 
Purified- and Reduced/Purified-pMMO, both in 45% H217O compared to natural abundance H2O 
(~0% 17O). If CuB(II) featured an equatorial HxO ligand, both H217O Purified- and H217O 5 
Reduced/Purified-pMMO would exhibit broadening of the 14N hyperfine lines relative to the 
natural abundance H2O samples, due to the large hyperfine coupling to the 17O (approximately 
equivalent to that of an equatorial N ligand) (67). However, neither sample exhibits such 
broadening. Conditions: 9.36-9.37 GHz microwave frequency, 90 s scan rate, 320 ms time 
constant, 12.5 G modulation amplitude, temperature 20 K. Protein concentrations of natural 10 
abundance Purified- and Reduced/Purified-pMMO were 167 µM. (B) Mims 17O-Larmor centered 
ENDOR testing for weakly-coupled 17O on CuB and CuC. The 17O hyperfine coupling A = 1.6 MHz 
observed in both H217O Reduced/Purified-pMMO and Purified-pMMO is of the magnitude 
expected for an axial HxO ligand (68). Thus, there exists an axially coordinated H2O on CuB. The 
larger coupling 17O A = 3.6 is attributed to a HxO coordinated to CuC. Conditions: 34.6-34.7 GHz 15 
microwave frequency, 20 ms repetition time (H217O Purified-pMMO and natural abundance 
Purified-pMMO), 100 ms repetition time (H217O Reduced/Purified-pMMO), π = 100 ns, TRF = 60 
µs, τ = 1400 ns and RF tail = 10 µs. (C) The equivalence of the Davies ENDOR responses between 
natural abundance and H217O Purified-pMMO samples in this region indicates that CuB does not 
feature an equatorial Hx17O ligand whose coupling would be ~30-33 MHz (17O Larmor frequency 20 𝑣 J*K  = 6.4 MHz) as shown previously (67). Conditions: 34.5-34.7 GHz microwave frequency, 20 
ms repetition time, π = 80 ns, TRF = 15 µs, τ = 475 ns, RF tail = 5 µs.  
  
Submitted Manuscript: Confidential 
17 
 
 
 
Fig. S7. Alternative analyses of DEER distance distributions showing that the feature at 4.5 nm is 
robust to analysis procedure, whereas the 2.8 nm feature is highly variable. The distribution shown 
in (A) is the same as that presented in Fig. 3. Analysis procedures: (A) manually optimized phase 5 
correction, zero time, using a 3rd order homogenous background function, followed by Tikhonov 
regularization. (B) Automatic phase correction, zero time, using a 2nd order homogenous 
background function, followed by Tikhonov regularization. (C) Automatic phase correction, zero 
time, using a 1st order polynomial background function, followed by Tikhonov regularization. (D) 
Automatic phase correction, zero time, using a 2nd order polynomial background function, 10 
followed by Tikhonov regularization. (E) Manually optimized phase correction, zero time, using 
a 2nd order homogenous background function, followed by Tikhonov regularization. (F) Automatic 
phase correction, zero time, using a 1st order polynomial background function, followed by 2 
Gaussian fit function. (G) Automatic phase correction, zero time, using a 1st order polynomial 
background function, followed by 2 Gaussian homogeneous fit function. 15 
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Fig. S8. Natural abundance Purified-pMMO before and after incubation with 2 M NaNO2. At this 
concentration of NaNO2, pMMO in bicelles has <25% methane oxidation activity relative to 5 
samples without NaNO2. (A) X-band CW-EPR showing nitrite-induced changes to the CuC(II) 
EPR signal, which are most evident in the g⫠ region (~3300 G), a collapse of the otherwise resolved 
features. Conditions: 9.365 GHz microwave frequency, 90 s scan rate, 320 ms time constant, 12.5 
G modulation amplitude, temperature 20 K. Purified- and Reduced/Purified-pMMO protein 
concentrations were 167 µM, while the Purified-pMMO sample after nitrite incubation was 83 10 
µM. (B) Q-band Mims ENDOR comparing natural abundance Purified-pMMO to natural 
abundance Purified-pMMO incubated with 2 M Na15NO2. The bottom expanded view shows the 
15N Larmor frequency (𝑣 )*+ ) region at higher signal/noise ratio, with the resolved hyperfine 
coupling of the magnitude expected for 15NO2– coordinated to the Cu(II) via oxygen(s) highlighted 
(A ~ 0.3 MHz) (42). Triangle defines the 𝑣 )*+  and associated goalpost width defines hyperfine 15 
coupling magnitude (|A|). Conditions: (top) 34.7 GHz microwave frequency, 20 ms repetition 
time, π = 100 ns, TRF = 60 µs, τ = 1400 ns, RF tail = 10 µs, Purified-pMMO scan time = 17 min, 
Purified-pMMO + Na15NO2 scan time = 40 min; (bottom) 34.7 GHz microwave frequency, 10 ms 
repetition time, π = 100 ns, TRF = 60 µs, τ = 1000 ns, RF tail = 10 µs, scan time = 3.5 hrs. 
  20 
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Fig. S9. Designed spmoB constructs used in 13C-methane oxidation activity assays. The PmoB 
subdomain 1 (PmoB D1) is joined to PmoB subdomain 2 (PmoB D2) by GB1-PmoA rather than 
the flexible linker used to join the two subdomains in spmoB. GFP11 corresponds to the fragment 5 
of GFP utilized for the split GFP assay, and Strep refers to the Strep-tag. Figure generated with 
Geneious version 9.1 created by Biomatters. 
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Fig. S10. Refolded SUMO7 and natural abundance Reduced/Purified-pMMO X-band EPR 
spectra, and SUMO7 13C-methane oxidation activity. (A) The inactive SUMO7 exhibits a CuB(II) 5 
EPR signal similar to Reduced/Purified-pMMO although the CuB(II) site formed in SUMO7 
cannot be identical to that of Reduced/Purified-pMMO since the N-terminal residue of SUMO7 is 
not His33 (and thus His33 cannot coordinate via both side chain and amine). Conditions: The 
SUMO7 and Reduced/Purified-pMMO concentrations are 250 and 167 µM, respectively. Spectra 
normalized to unity. SUMO7, 9.125 GHz microwave frequency, 1 min scan rate, 30 ms time 10 
constant, 4 G modulation amplitude, 77 K temperature; natural abundance Reduced/Purified-
pMMO, 9.367 GHz microwave frequency, 90 s scan rate, 320 ms time constant, 12.5 G modulation 
amplitude, 20 K temperature. (B) 13C-methane oxidation activity assay of the same batch of 
refolded SUMO7 as probed by EPR in (A). The SUMO7 protein concentration was 50 µM. 
SUMO7 does not exhibit methane oxidation activity above that observed for control reactions 15 
which do not feature CuB (e.g. NeMCO and Con7_3A in Fig. S11). Error bars indicate n = 3 
replicates of reaction assay samples. 
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* For 1 of the 4 "(+) spmoB, Full Rxn" replicates in (B), the entire MS-detected elution profile off 
the GC column was anomalous, so the replicate was omitted. 
 
Fig. S11. Results of 13C-methane oxidation activity assays performed on spmoB, its variants, as 
well as NeMCO. Representative assays in which appreciable 13C-methanol was observed are 5 
shown. There were other assays run under the same conditions in which no samples showed any 
13C-methanol. Error bars indicate n ≥ 2 replicates of reaction assay samples. (A) Standard spmoB 
reaction time/temperature (24) generates 13C-methanol from 13C-methane, although the spmoB 
protein concentration (~30 µM) was lower than traditionally assayed for activity (~100 µM). (B) 
The 12C-methanol absolute MS responses are consistently higher in samples containing both 10 
spmoB and duroquinol than in conditions with either individually or neither. While the 12C-
methanol levels are higher on average in the "(+) protein, No CH4" than in the "(+) protein, Full 
Rxn" for this assay, this trend was often reversed, as shown in (C). In these such situations, where 
12C-methanol was produced over the course of the assay and the "(+) protein, Full Rxn" sample 
accumulated more 12C-methanol than the "(+) protein, No CH4" control, the spmoB construct 15 
would have appeared active using the GC-FID method of total methanol quantitation, as performed 
previously (24, 27). The differences in 12C-methanol levels for samples containing both spmoB 
and duroquinol can be attributed to minor differences in the amount of duroquinol added since 
standard protocol calls for addition of a small scoop of this insoluble compound. Moreover, 12C-
methanol is a common contaminant in many buffer reagents. As 13C represents ~1% of natural 20 
abundance carbon, we monitored 12C-methanol levels to ensure that any 13C-methanol observed 
after reaction was a product of methane oxidation, and not merely observation of the natural 
abundance 13C-methanol from 12C-methanol contamination. The spmoB protein concentration was 
100 µM.  (C) Top: 13C-methanol produced via spmoB construct reaction with 13C-methane, with 
bottom: 12C-methanol responses. Con7, SUMO7, and SUMO7_E75D protein concentrations were 25 
22 µM, 6 µM, and 17 µM, respectively. (D) 13C-methane oxidation activity assays run overnight 
on several spmoB constructs as well as NeMCO. The activity detected for spmoB variant 
constructs is comparable to that observed for an unrelated enzyme (NeMCO) or a variant in which 
all three CuB His ligands are replaced with Ala (Con7_3A). SUMO7, SUMO7_E75D, NeMCO, 
and Con7_3A protein concentrations were 114 µM, 118 µM, 60 µM, and 131 µM, respectively. 30 
(E) 13C-methane oxidation activity of diluted samples. There is no dependence on protein 
concentration. Initial Con7_3A, SUMO7_E75D, and NeMCO protein concentrations (prior to 
dilution) are same as in (D).  
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Fig. S12. Rapid-passage Q-band absorption-display CW EPR spectra of the 3 EPR samples shown 
in Fig. 1 and 2. The Cu(II) resonance is by far the dominant paramagnetic species. We note the 
extremely weak g ~ 1.95 feature in Vivo-pMMO, the intensity of which is exaggerated in the 5 
derivative-display of the X-band spectrum in Fig. 1 (~3470 G); this feature contributes negligible 
integrated intensity. Asterisks denote the hyperfine lines for the small amount of Mn(II) (I = 5/2). 
Conditions: (Purified- and Reduced/Purified-pMMO) ~34.8 GHz microwave frequency, 2 min 
and 45 second scan rate, 64 ms time constant, 1 G modulation amplitude, temperature ~ 2 K. (Vivo-
pMMO) is the same as the others except scan rate was twice as fast. 10 
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Fig. S13. Vivo-pMMO weakly-coupled 15N Mims ENDOR showing both v+ and v- resonance, 
measured at g1 and g2. Triangle defines 𝑣 )*+  and goalpost splittings define v+ and v- partners; red 5 
arrows denote Mims "holes". For the Mims pulse sequence, the ENDOR response (R) is defined 
by the equation 𝑅	~	1 − cos(2𝜋𝐴τ). Consequently, for all integer values of Aτ the ENDOR 
response/intensity is 0, leading to the so-called Mims "holes". For both 15N-Larmor corrected 
spectra above, τ was chosen such that Mims holes appear every |A| = Z(2 MHz), where Z is an 
integer. The g1 15N v+ and v- responses both show such Mims holes (at 𝑣 )*+  ±1 MHz), confirming 10 
their assignment to weakly-coupled 15N resonance. We note these must be Mims holes, as Fig. 2 
indicates that for appropriate values of τ, 15N resonance is non-zero at this frequency. The 
microwave amplifier employed for these measurements cannot measure frequencies low enough 
to observe the full v- peak at g1. Collection conditions: 34.64 GHz microwave frequency, 50 ms 
repetition time, π = 100 ns, τ = 500 ns, TRF = 60 µs, and RF tail = 10 µs. 15 
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Fig. S14. PESTRE hyperfine sign assignments for strongly-coupled 15N resonance in Vivo-
pMMO. Top: Davies ENDOR measurements defining the 15N resonance at g1. Bottom: PESTRE 
responses measured at measured at g1. The PESTRE experiment utilizes three discrete Davies 
ENDOR sequences. First, a baseline signal is established (BSL) during which time the microwave 5 
is applied with no RF, saturating the EPR transition. Next, a single frequency RF is applied to 
saturate the ENDOR transition (ENDOR). Finally, the RF is turned off (DRL) and the direction of 
echo relaxation relative to the BSL (DRLδ ≡ DRL - BSL) defines the manifold producing the 
observed resonance (labeled as α or β to indicate the higher or lower energy electron spin 
manifolds, respectively). For v+ DRLδ > 0, A/gn < 0, while v+ DRLδ < 0 defines A/gn > 0; likewise, 10 
for v- DRLδ < 0, A/gn < 0, while v- DRLδ > 0 defines A/gn > 0. Consequently, as expected, the 
PESTRE measurements are consistent with exclusively strongly-coupled 15N A/gn > 0, indicating 
a positive spin density ρ > 0 since ρ ∝ A/gn. Collection conditions: 34.5-34.6 GHz microwave 
frequency, 100 ms repetition time, π = 80 ns, τ = 600 ns, TRF = 15 µs, and RF tail = 5 µs. 
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Fig. S15. X-band CW EPR of the Purified-pMMO sample used for DEER measurements (buffer 
conditions: 50 mM PIPES, 500 mM NaCl, 0.04% DDM, pH 7.2). Bracket width denotes A1 Cu 5 
hyperfine splitting, and the center of the brackets indicate g1 using the values from Table S1. 
Asterisk denotes an instrument artifact sometimes observed on the spectrometer. The altered buffer 
conditions do not alter the CuB(II) or CuC(II) signals from those observed under the standard 
Purified-pMMO buffer conditions (as in Fig. 1). Collection conditions: 9.366 GHz microwave 
frequency, 90 s scan rate, 320 ms time constant, 12.5 G modulation amplitude, 20 K temperature, 10 
5 scans. 
Submitted Manuscript: Confidential 
27 
 
 
 
 
Fig. S16. 15N Davies ENDOR measured at g2 for Vivo-, Purified-, and Reduced/Purified-pMMO. 
Intensities normalized to match those of 15N in Fig. S3A. Goalpost width indicates twice the 15N 5 
Larmor frequency (𝑣 )*+ ), filled circle defines half the hyperfine coupling magnitude (|A/2|). 
Collection conditions: 34.5-34.7 GHz microwave frequency, 50 ms repetition time, π = 80 ns, τ = 
400 ns, TRF = 15 µs, and RF tail = 5 µs. 
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